Efficacy and Safety of the Natural Killer T Cell–Stimulatory Glycolipid OCH-NCNP1 for Patients With Relapsing Multiple Sclerosis: Protocol for a Randomized Placebo-Controlled Clinical Trial

Tomoko Okamoto   ¹ , MD, PhD ;   Takami Ishizuka   ² , PhD ;   Reiko Shimizu   ² , MD, PhD ;   Yasuko Asahina   ² , PhD ;   Harumasa Nakamura   ² , MD, PhD ;   Yuko Shimizu   ³ , MD, PhD ;   Yoichiro Nishida   ⁴ , MD, PhD ;   Takanori Yokota   ⁴ , MD, PhD ;   Youwei Lin   ^{1, 5} , MD ;   Wakiro Sato   ⁵ , MD, PhD ;   Takashi Yamamura   ⁵ , MD, PhD

¹ Department of Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan

² Department of Clinical Research Support, Clinical Research and Education Promotion Division, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan

³ Department of Neurology, Tokyo Women's Medical University, Tokyo, Japan

⁴ Department of Neurology and Neurological Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan

⁵ Department of Immunology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan